Pleco Therapeutics BV

A bevy of big venture capital financings have been announced since Labor Day, the official end of summer in the US, led by a $300m series C round for Acelyrin, Inc. The boom in VC mega-deals is rema

Belgian value-added medicines company Hyloris Pharmaceuticals SA has outlined an ambitious growth strategy while announcing its financial and operational results for the full-year ending 31 December

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sanofi Hopes Owkin Can Aid Oncology Dis